Evidence map›Paper›PMID 21840425›Full record

SynthesisAutoimmunity reviews2012

Evaluation of genetic association between an ITGAM non-synonymous SNP (rs1143679) and multiple autoimmune diseases.

Juan-Manuel Anaya, Xana Kim-Howard, Sampath Prahalad, Alejandra Cherñavsky, Carlos Cañas, Adriana Rojas-Villarraga, John Bohnsack, Roland Jonsson, Anne Isine Bolstad, Johan G Brun and 5 more

Open access · greenAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in Autoimmunity reviews, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 4 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 4 syntheses or guidelines pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Mice expressing the variant rs1143679 allele of ITGAM (CD11b) show impaired DC-mediated T cell proliferation.Mammalian genome : official journal of the International Mammalian Genome Society · 2019
    Article
  18. Article
  19. A Novel Association of Polymorphism in theMediators of inflammation · 2018
    Article
  20. Genetics of human lupus nephritis.Clinical immunology (Orlando, Fla.) · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 4 countries.

Juan-Manuel AnayaCenter for Autoimmune Diseases Research (CREA), Universidad del Rosario, Bogotá, Colombia.
Xana Kim-Howard
Sampath Prahalad
Alejandra Cherñavsky
Carlos Cañas
Adriana Rojas-Villarraga
John Bohnsack
Roland Jonsson
Anne Isine Bolstad
Johan G Brun
Beth Cobb
Kathy L Moser
Judith A James
John B Harley
Swapan K Nath
Oklahoma Medical Research Foundation · USUniversidad del Rosario · COUniversity of Bergen · NOCincinnati Children's Hospital Medical Center · USEmory University · USFundación Valle del Lili · COHaukeland University Hospital · NOHospital de Clínicas "José de San Martín" · ARUniversity of Oklahoma Health Sciences Center · USUniversity of Utah · US

Funding

THE EFFECTS OF ERK PATHWAY INHIBITION ON DNA METHYLATION IN SLEP20RR015577 · NCRR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GUTHRIDGE, JOEL MARVIN · 2000 to 2009
$21.5M
VALIDATING NOVEL GENES IMPLICATED IN LEUKOCYTE CHEMOTAXISP20RR020143 · NCRR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI ALARCON-RIQUELME, MARTA E · 2004 to 2011
$21.0M
Program Project in the Genetics of SLEP01AR049084 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2002 to 2012
$12.7M
SequencingP01AI083194 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI ALARCON-RIQUELME, MARTA E · 2009 to 2013
$9.6M
SNP Confirmation and High Throughput Genotyping CoreP30AR053483 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GUTHRIDGE, JOEL MARVIN · 2007 to 2017
$6.7M
Pre-Clinical Studies to Identify SLE Therapeutic TargetsU19AI082714 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2009 to 2018
$6.2M
GENETIC ASSOCIATION WITH LUPUS IN AMERICAN BLACKSR01AR042460 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI HARLEY, JOHN BARKER · 1993 to 2009
$5.1M
Genetic Linkage in LupusR37AI024717 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI HARLEY, JOHN BARKER · 2005 to 2014
$4.2M
Science in a Culture of MentoringP30GM103510 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JAMES, JUDITH A · 2012 to 2016
$3.9M
SLE Susceptibility and Clinical Significance at 2q22-24 across Multiple EthnicitiR01AR060366 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI NATH, SWAPAN K. · 2010 to 2019
$3.3M
Science in a Culture of MentoringP30RR031152 · NCRR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI MUNROE, MELISSA E · 2010 to 2011
$2.4M
Genetic Association in Sjogren's SyndromeR01DE015223 · NIDCR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI HARLEY, JOHN BARKER · 2004 to 2008
$1.9M
NCRR NIH HHS P20 RR015577NCRR NIH HHS P20 RR020143NCRR NIH HHS P20RR020143NCRR NIH HHS P20RR15577NCRR NIH HHS P30 RR031152NCRR NIH HHS P30RR031152NIAID NIH HHS P01 AI083194NIAID NIH HHS P01AI083194NIAID NIH HHS R01 AI063622NIAID NIH HHS R01AI063622NIAID NIH HHS R21 AI094377NIAID NIH HHS R21AI094377NIAID NIH HHS R37 AI024717NIAID NIH HHS R37AI024717NIAID NIH HHS U19 AI082714NIAID NIH HHS U19AI082714NIAMS NIH HHS K23 AR050177NIAMS NIH HHS K23AR50177NIAMS NIH HHS N01-AR02551NIAMS NIH HHS N01 AR062277NIAMS NIH HHS P01 AR049084NIAMS NIH HHS P01AR049084NIAMS NIH HHS P30 AR053483NIAMS NIH HHS P30AR053483NIAMS NIH HHS R01 AR042460NIAMS NIH HHS R01AR042460NIAMS NIH HHS R01 AR060366NIAMS NIH HHS R01AR060366NIDCR NIH HHS R01 DE015223NIDCR NIH HHS R01DE015223NIDCR NIH HHS R01 DE018209NIDCR NIH HHS R01DE018209NIGMS NIH HHS P30 GM103510
6 · The paper itself

Abstract

Many autoimmune diseases (ADs) share similar underlying pathology and have a tendency to cluster within families, supporting the involvement of shared susceptibility genes. To date, most of the genetic variants associated with systemic lupus erythematosus (SLE) susceptibility also show association with others ADs. ITGAM and its associated 'predisposing' variant (rs1143679, Arg77His), predicted to alter the tertiary structures of the ligand-binding domain of ITGAM, may play a key role for SLE pathogenesis. The aim of this study is to examine whether the ITGAM variant is also associated with other ADs. We evaluated case-control association between rs1143679 and ADs (N=18,457) including primary Sjögren's syndrome, systemic sclerosis, multiple sclerosis, rheumatoid arthritis, juvenile idiopathic arthritis, celiac disease, and type-1 diabetes. We also performed meta-analyses using our data in addition to available published data. Although the risk allele 'A' is relatively more frequent among cases for each disease, it was not significantly associated with any other ADs tested in this study. However, the meta-analysis for systemic sclerosis was associated with rs1143679 (p(meta)=0.008). In summary, this study explored the role of ITGAM in general autoimmunity in seven non-lupus ADs, and only found association for systemic sclerosis when our results were combined with published results. Thus ITGAM may not be a general autoimmunity gene but this variant may be specifically associated with SLE and systemic sclerosis.

Indexed as

Genetic Predisposition to DiseaseAutoimmune DiseasesCD11b AntigenDNA Mutational AnalysisEuropeGene FrequencyGenetic Association StudiesGenotypeHumansLatin AmericaPolymorphism, Single NucleotideCD11b AntigenITGAM protein, human

Identifiers

PMID21840425
PMCPMC3224188
OpenAlexW2028486393

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.